Glaukos (GKOS) Operating Income (2014 - 2026)
Glaukos' (GKOS) quarterly Operating Income came in at -$19.9 million in Q1 2026, up 3.98% year-on-year from -$19.1 million in Q1 2025, and up 85.8% on a QoQ basis from -$139.9 million in Q4 2025.
Glaukos (GKOS) Operating Income (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Operating Income data on file, last reported at -$19.9 million in Q1 2026.
- On a quarterly basis, Operating Income rose 3.98% year-over-year to -$19.9 million in Q1 2026; TTM through Mar 2026 was -$198.8 million, a 91.17% decrease from a year earlier, with the FY2025 full-year figure at -$199.6 million, down 63.12% from the prior year.
- Operating Income for Q1 2026 stood at -$19.9 million, up from -$139.9 million in the prior quarter.
- Over the last five years, Operating Income for GKOS reached as high as $9.8 million in Q1 2022 and fell as low as -$139.9 million in Q4 2025.
- Historically, Operating Income has averaged -$32.5 million across 5 years, with a median of -$28.7 million in 2024.
- Across the five-year window, Operating Income surged 182.95% in 2022 and tumbled 436.94% in 2023, its largest moves.
- Year by year, Operating Income stood at -$33.7 million in 2022, then slipped by 14.49% to -$38.6 million in 2023, then gained by 25.78% to -$28.7 million in 2024, then slumped by 387.92% to -$139.9 million in 2025, then surged by 85.8% to -$19.9 million in 2026.
- Per Business Quant data, the three most recent Operating Income figures were -$19.9 million in Q1 2026, -$139.9 million in Q4 2025, and -$16.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn | -19.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.86 Mn |
| Dec 31, 2025 | -139.87 Mn |
| Sep 30, 2025 | -16.37 Mn |
| Jun 30, 2025 | -22.69 Mn |
| Mar 31, 2025 | -20.68 Mn |
| Dec 31, 2024 | -28.67 Mn |
| Sep 30, 2024 | -24.66 Mn |
| Jun 30, 2024 | -29.97 Mn |
| Mar 31, 2024 | -39.07 Mn |
| Dec 31, 2023 | -38.62 Mn |
| Sep 30, 2023 | -28.01 Mn |
| Jun 30, 2023 | -29.08 Mn |
| Mar 31, 2023 | -32.99 Mn |
| Dec 31, 2022 | -33.73 Mn |
| Sep 30, 2022 | -21.61 Mn |
| Jun 30, 2022 | -36.76 Mn |
| Mar 31, 2022 | 9.79 Mn |
| Dec 31, 2021 | -17.87 Mn |
| Sep 30, 2021 | 11.02 Mn |
| Jun 30, 2021 | -14.22 Mn |